Renaissance Technologies’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-27,700
| Closed | -$36K | – | 4151 |
|
|
2022
Q2 | $36K | Sell |
27,700
-174,318
| -86% | -$227K | ﹤0.01% | 4050 |
|
|
2022
Q1 | $325K | Sell |
202,018
-13,382
| -6% | -$21.5K | ﹤0.01% | 3435 |
|
|
2021
Q4 | $446K | Buy |
215,400
+205,304
| +2,034% | +$425K | ﹤0.01% | 3129 |
|
|
2021
Q3 | $39K | Sell |
10,096
-360,103
| -97% | -$1.39M | ﹤0.01% | 3388 |
|
|
2021
Q2 | $1.19M | Buy |
370,199
+63,199
| +21% | +$202K | ﹤0.01% | 2581 |
|
|
2021
Q1 | $666K | Buy |
307,000
+291,373
| +1,865% | +$632K | ﹤0.01% | 2794 |
|
|
2020
Q4 | $35K | Buy |
+15,627
| New | +$35K | ﹤0.01% | 3331 |
|
|
2020
Q2 | – | Sell |
-20,100
| Closed | -$39K | – | 3558 |
|
|
2020
Q1 | $39K | Sell |
20,100
-19,000
| -49% | -$36.9K | ﹤0.01% | 3343 |
|
|
2019
Q4 | $112K | Buy |
+39,100
| New | +$112K | ﹤0.01% | 3301 |
|
|
2019
Q3 | – | Sell |
-34,732
| Closed | -$144K | – | 3511 |
|
|
2019
Q2 | $144K | Buy |
+34,732
| New | +$144K | ﹤0.01% | 3354 |
|
|
2018
Q3 | – | Sell |
-37,300
| Closed | -$237K | – | 3402 |
|
|
2018
Q2 | $237K | Buy |
+37,300
| New | +$237K | ﹤0.01% | 3038 |
|